Abstract
BackgroundOur previous study has shown that regardless of a relatively high amount of cholesterol, squid homogenate lowers serum and hepatic cholesterol in animals. Since this work, we have developed a new method to inhibit autolysis of squid proteins with sodium citrate. This study aims to investigate how squid homogenate prepared with sodium citrate affects lipid metabolism in Sprague–Dawley rats at the molecular level.MethodsWe prepared squid homogenate with sodium citrate to inhibit autolysis of squid protein. In Experiment 1 (Exp. 1), rats were given a cholesterol-free control diet or a squid diet, with squid homogenate added at the level of 5% as dietary protein for 4 weeks. Blood, the liver and adipose tissue were taken after 6 hours fasting. Serum and hepatic lipids and activities of enzymes related to lipid metabolism were measured. In Experiment 2 (Exp. 2), the above-mentioned diets had cholesterol added at the level of 0.1% and given to rats. Lipid parameters, enzyme activities, and gene expression of proteins involved in lipid metabolism in the liver and the small intestine were determined. In addition, feces were collected for two days at the end of Exp. 2 to measure fecal excretion of steroids.ResultsIn Exp.1, serum triglyceride and cholesterol were ~50% and ~20% lower, respectively, in the squid diet-fed rats than in the control diet-fed animals while hepatic cholesterol was ~290% higher in the squid diet-fed rats. When cholesterol was included into the diets (Exp. 2), serum lipids were significantly lower in the squid group while no difference of hepatic lipid was seen between two groups. Activities of hepatic lipogenic enzymes were significantly lower in rats on the squid diet while the enzyme responsible for fatty acid oxidation was not modified (Expt. 1 and 2). Hepatic level of mRNA of microsomal triglyceride transfer protein was significantly lower in the squid group. In the small intestine, the squid diet exhibited significantly lower gene expression of proteins involved in fatty acid transport and cholesterol absorption. Fecal secretion of acidic steroids, but not neutral steroids, was higher in rats fed the squid diet than in those fed the control diet.ConclusionThese results imply that newly-developed squid homogenate has hypolipidemic potential primarily through decreased absorption of bile acids in the small intestine and suppressed lipogenesis in the liver.
Highlights
Our previous study has shown that regardless of a relatively high amount of cholesterol, squid homogenate lowers serum and hepatic cholesterol in animals
Experiment 1 As shown in Table 1, body weight gain and liver weight were not affected by the diets while the squid diet animals had significantly lower food intake and perirenal adipose tissue weight compared to the control diet animals
Cholesterol and phospholipid were significantly lower in rats fed the squid diet compared to those fed the control diet (Table 2); triglyceride level was ~50% lower in rats on the squid diet
Summary
Our previous study has shown that regardless of a relatively high amount of cholesterol, squid homogenate lowers serum and hepatic cholesterol in animals. The role of other constituents in fish such as protein in development of various diseases has been less conclusive compared to those of fish oil, fish proteins appear to be less hyperlipidemic than animal proteins [8,9,10,11]. Some shellfish such as crab, squid and shrimp have a relatively high content of cholesterol [12], which often discourages subjects with hypercholesterolemia from eating them. Squid homogenate prepared with sodium citrate could contain more intact proteins compared to squid homogenate used in the previous study [15]. The aim of this study was to see if newlydeveloped squid homogenate lowers lipid levels in blood and the liver, and to determine how squid homogenate modifies lipid metabolism at the molecular level
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have